Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism Bacterial quorum sensing protein inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H19NO5 |
InChIKeyLUEPJAKFYBKTDR-NWDGAFQWSA-N |
CAS Registry97652-53-4 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pseudomonas aeruginosa infection | Preclinical | Italy | 09 Oct 2024 | |
| Pseudomonas aeruginosa infection | Preclinical | Italy | 09 Oct 2024 | |
| Staphylococcus Aureus Infections | Preclinical | Italy | 09 Oct 2024 | |
| Staphylococcus Aureus Infections | Preclinical | Italy | 09 Oct 2024 |





